Skip to Main Content

Paper Details

MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling.
Mol Cancer Ther
0
2024
Author NameAffiliation
Gregory J RielyMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2